text: <unk>  is an immunosuppressant that is FDA approved for the {{{indicationType}}} of relapsing forms of multiple sclerosis.   Common adverse reactions include injection site reactions, vasodilatation, rash, dyspnea, and chest pain.
option_0: Glatiramer
option_1: Riluzole
option_2: Abatacept
option_3: Belatacept
option_4: Anakinra
option_5: Atezolizumab
option_6: Tocilizumab
option_7: Nebacumab